Company intelligence / Profile preview

OJ-Bio

Newcastle upon Tyne, England, United Kingdomoj-bio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Developed a rapid point-of-care diagnostic device using a biochip and wireless-enabled reader for flu diagnosis. The technology aimed to provide fast results at the patient’s side to improve early detection and treatment. Clinical trials were planned but no published results are available as of the latest data.

Therapeutic areas: Infectious Diseases
Modalities: DeviceBiosensor platform
Industry: Protein Biomarker Diagnostics

Partnerships

Orla Protein Technologies Ltd.Japan Radio Company (JRC)

Beyond the preview

Go deeper on OJ-Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OJ-Bio.

Explore the full profile